Aveo Pharmaceuticals Inc (AVEO.OQ)

AVEO.OQ on NASDAQ Stock Exchange Global Select Market

0.96USD
24 Oct 2014
Price Change (% chg)

$-0.06 (-5.88%)
Prev Close
$1.02
Open
$1.02
Day's High
$1.02
Day's Low
$0.95
Volume
29,067
Avg. Vol
63,320
52-wk High
$2.34
52-wk Low
$0.85

AVEO.OQ

Chart for AVEO.OQ

About

AVEO Pharmaceuticals, Inc., doing business as AVEO Oncology, is a biopharmaceutical company. The Company is engaged in discovering, developing, and commercializing targeted cancer therapies using its Human Response Platform. Its therapeutic candidates under development program include AV-203, an anti-ErbB3 monoclonal antibody... (more)

Overall

Beta: 1.08
Market Cap (Mil.): $50.73
Shares Outstanding (Mil.): 52.30
Dividend: --
Yield (%): --

Financials

  AVEO.OQ Industry Sector
P/E (TTM): -- 161.00 34.06
EPS (TTM): -1.27 -- --
ROI: -57.66 -1.64 17.45
ROE: -83.97 -6.68 18.26
Search Stocks

Competitors

  Price Change
Takeda Pharmaceutical Co Ltd (4502.T) ¥4,538 +52.00
DAIICHI SANKYO COMPANY, LIMITED (4568.T) ¥1,678 +43.00
Eisai Co., Ltd (4523.T) ¥4,250 +80.00
Pfizer Inc. (PFE.N) $29.11 +0.51
Novartis AG (NOVN.VX) CHF85.75 +0.35
Roche Holding Ltd. (ROG.VX) CHF278.00 -1.40
Bayer AG (BAYGn.DE) €95.41 -2.28
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €84.60 -0.30
AstraZeneca plc (AZN.L) 4,327.50p -7.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks